Bosh sahifa04K • FRA
add
Knight Therapeutics Inc
Yopilish kursi
3,64 €
Kunlik diapazon
3,72 € - 3,72 €
Yillik diapazon
3,40 € - 4,10 €
Bozor kapitalizatsiyasi
577,84 mln CAD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 88,08 mln | 1,70% |
Joriy xarajat | 40,40 mln | 3,49% |
Sof foyda | 2,18 mln | 148,06% |
Sof foyda marjasi | 2,48 | 147,24% |
Har bir ulushga tushum | 0,02 | 150,00% |
EBITDA | 6,05 mln | -60,32% |
Amaldagi soliq stavkasi | 647,62% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 180,86 mln | -5,84% |
Jami aktivlari | 1,00 mlrd | 3,60% |
Jami passivlari | 207,60 mln | 0,62% |
Umumiy kapital | 795,44 mln | — |
Tarqatilgan aksiyalar | 99,63 mln | — |
Narxi/balansdagi bahosi | 0,46 | — |
Aktivlardan daromad | -1,41% | — |
Kapitaldan daromad | -1,63% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,18 mln | 148,06% |
Operatsiyalardan naqd pul | 3,67 mln | -88,12% |
Sarmoyadan naqd pul | 32,13 mln | 231,85% |
Moliyadan naqd pul | -4,70 mln | -62,20% |
Naqd pulning sof oʻzgarishi | 32,05 mln | 686,67% |
Boʻsh pul | -7,56 mln | -883,33% |
Haqida
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Tashkil etilgan
2014
Bosh ofis
Sayt
Xodimlar soni
745
